Article
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
9 Dec 2009
Abstract excerpt
BACKGROUND: Myeloablative allogeneic hematopoietic stem-cell transplantation is curative in children with sickle cell disease, but in adults the procedure is unduly toxic. Graft rejection and graft-versus-host disease (GVHD) are additional barriers to its success. We performed nonmyeloablative stem-cell transplantation in adults with sickle cell disease. METHODS: Ten adults (age range, 16 to 45 years) with severe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
